Table 2 Relationship between SUSD2 expression and clinicopathological characteristics of HCC patients
Characteristics | Total | SUSD2 staining | Pearson Chi square | P valueb | |
|---|---|---|---|---|---|
Negative (%) | Positive (%) | ||||
Ages (years) | 0.31 | 0.861 | |||
≤42a | 45 | 27 (60.0) | 18 (40.0) | ||
>42 | 135 | 79 (58.5) | 56 (41.5) | ||
Sex | 1.093 | 0.296 | |||
Female | 45 | 29 (64.4) | 16 (35.6) | ||
Male | 135 | 75 (55.6) | 60 (44.4) | ||
Histological grade | 5.198 | 0.023 | |||
G1–G2 | 154 | 88 (57.1) | 66 (42.9) | ||
G3 | 26 | 21 (80.8) | 5 (19.2) | ||
Clinical stage | 30.244 | 0.000 | |||
I–II | 66 | 23 (34.8) | 43 (65.2) | ||
III–IV | 114 | 87 (76.3) | 27 (23.7) | ||
pT status | 33.175 | 0.000 | |||
T1–T2 | 76 | 24 (31.6) | 52 (68.4) | ||
T3 | 104 | 78 (75) | 26 (25) | ||
pN status | 4.785 | 0.029 | |||
N0 | 160 | 63 (39.4) | 97 (60.6) | ||
N1 | 20 | 13 (65) | 7 (35) | ||
pM status | 4.620 | 0.032 | |||
M0 | 164 | 67 (40.9) | 97 (59.1) | ||
M1 | 16 | 11 (68.7) | 5 (31.3) | ||